DangerousContraindicated
Combining escitalopram with St. John's Wort significantly increases the risk of serotonin syndrome. Escitalopram is the most selective SSRI, and adding St. John's Wort's serotonergic activity creates dangerous serotonin excess. St. John's Wort may also reduce escitalopram levels via CYP3A4 induction while paradoxically increasing serotonin toxicity risk.
Recommendation: Do not take St. John's Wort with escitalopram. If mood support beyond your SSRI is needed, discuss evidence-based options with your prescriber.
SeriousContraindicated
5-HTP increases serotonin synthesis while escitalopram potently blocks serotonin reuptake. This combination creates significant risk of serotonin syndrome through complementary mechanisms that both increase synaptic serotonin availability.
Recommendation: Do not combine 5-HTP with escitalopram. If you are currently using both, discontinue 5-HTP and inform your prescriber.
SeriousCaution
SAMe has serotonergic properties that may potentiate escitalopram's effects. While some psychiatrists use SAMe augmentation in treatment-resistant depression, the combination requires careful monitoring due to the risk of excessive serotonergic stimulation.
Recommendation: Only combine SAMe with escitalopram under direct psychiatric supervision. Do not add SAMe on your own. Start at low doses if prescribed together, and monitor for signs of serotonin excess.
SeriousCaution
L-Tryptophan increases serotonin synthesis as its biosynthetic precursor. Combined with escitalopram's selective serotonin reuptake inhibition, the resulting increase in both serotonin production and synaptic retention can trigger serotonin syndrome.
Recommendation: Avoid supplemental L-tryptophan while taking escitalopram. If you wish to support mood through diet, discuss safe options with your prescriber.
SeriousCaution
Both amiodarone and escitalopram can prolong the QT interval. Combined use increases the risk of dangerous cardiac arrhythmias, particularly torsades de pointes.
Recommendation: Monitor ECG closely if combined. Consider alternative antidepressant with lower QT prolongation risk (e.g., sertraline). Keep electrolytes balanced.
ModerateCaution
Escitalopram is serotonergic. Rhodiola has preclinical monoamine and MAO-related findings, but direct human evidence for serotonin syndrome with Escitalopram is limited. Combined use should be treated as a theoretical serotonergic-interaction risk, not as a proven prescription-MAOI-like contraindication.
Recommendation: Do not use Rhodiola to self-augment Escitalopram. Discuss Rhodiola with the prescriber or pharmacist first, especially if other serotonergic agents are present, and seek care for serotonin-toxicity symptoms if both are used.
DangerousContraindicated
Escitalopram blocks the serotonin transporter that MDMA uses to release serotonin, blunting MDMA's intended effect while still producing serotonergic load and hyperthermia. The combination carries documented risk of serotonin syndrome and cardiovascular collapse, especially in young adults.
Recommendation: Do not combine MDMA with escitalopram. If you stop escitalopram, wait at least 1-2 weeks before any MDMA exposure.
ModerateCaution
Escitalopram impairs platelet aggregation by depleting platelet serotonin stores, and high-dose fish oil adds modest antiplatelet activity by reducing thromboxane A2 synthesis. Combined use raises bleeding risk, particularly with NSAIDs or anticoagulants.
Recommendation: Keep fish oil dose moderate (≤1g/day) with escitalopram. Avoid high-dose regimens (>3g/day) unless your prescriber agrees, and stop fish oil 7 days before any planned surgery.
ModerateCaution
Escitalopram impairs platelet aggregation by depleting platelet serotonin; Ginkgo's ginkgolides inhibit platelet-activating factor. Combined antiplatelet activity raises bleeding risk, especially with concurrent NSAIDs or anticoagulants.
Recommendation: Avoid Ginkgo biloba while taking escitalopram. Watch for unusual bruising or bleeding; stop Ginkgo 7-14 days before any planned surgery.
NutriStack